Key result
Ropivacaine peripheral nerve infusion, intravenous ketamine, and multimodal analgesia were safely used for pain management in a young woman with Brugada syndrome.
Why the study?
Although anesthesia recommendations exist for patients with Brugada syndrome, guidance on pain management is limited.
Case Report (n=1)
This case report provides an example of a safe multimodal analgesic approach, including ropivacaine and ketamine infusions, for pain management in a patient with Brugada syndrome.
May support ketamine and regional anesthesia for pain in Brugada syndrome; hypothesis-generating and requires prospective validation.
Brugada syndrome is a rare condition that increases the risk of life-threatening arrhythmias. Although there are existing anesthesia recommendations for patients with Brugada syndrome, guidance on pain management is limited. We present a novel approach to pain management in these patients, illustrated by the case of a young woman with Brugada syndrome who underwent ropivacaine peripheral nerve infusion and intravenous ketamine infusion for acute-on-chronic left upper limb pain. She received perioperative multimodal analgesia, which included neuropathic agents (pregabalin, duloxetine), and opioids (morphine, codeine). Our findings contribute to a greater understanding of safe analgesic practices for patients with Brugada syndrome.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2025) conducted a case report in Brugada syndrome (n=1). Ropivacaine peripheral nerve infusion and intravenous ketamine infusion was evaluated. Ropivacaine peripheral nerve infusion, intravenous ketamine, and multimodal analgesia were safely used for pain management in a young woman with Brugada syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: